| 000 | 01413 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513155758.0 | ||
| 264 | 0 | _c19990413 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0167-6997 | ||
| 024 | 7 |
_a10.1023/a:1006100900082 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnson, S A | |
| 245 | 0 | 0 |
_aPhase I/II evaluation of pentostatin (2'-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia. _h[electronic resource] |
| 260 |
_bInvestigational new drugs _c1998 |
||
| 300 |
_a155-60 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPentostatin _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aCatovsky, D | |
| 700 | 1 | _aChild, J A | |
| 700 | 1 | _aNewland, A C | |
| 700 | 1 | _aMilligan, D W | |
| 700 | 1 | _aJanmohamed, R | |
| 773 | 0 |
_tInvestigational new drugs _gvol. 16 _gno. 2 _gp. 155-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1006100900082 _zAvailable from publisher's website |
| 999 |
_c9811688 _d9811688 |
||